Home / 207940.KS : KSC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does 207940.KS make money? Does 207940.KS have pricing power? What's the Earnings Whisper? Will 207940.KS profit more as the business scales? What is 207940.KS's management track record? Is 207940.KS's current price justified?

Samsung Biologics Co.,Ltd.

₩1420000 -$263000.00 (-15.63%)

KSC · 14 Sep 2026 06:30 UTC

Previous Close

₩1415000

Day Range

₩1381000₩1438000

Year Range

₩1228000₩1987000

Market Cap

65.73T

AVG Volume

66.14K

Trailing/Forward PE

33.11/28.98

PEG ratio

1.78

Dividend Yield

Next Earnings Date

2026-10-27

Primary Exchange

Korea Exchange

Revenue (KRW)

207940.KS Revenue (KRW) by year
Period	Revenue (KRW)
2025	4.56T
2024	4.55T
2023	3.69T
2022	3T
2021	1.57T
2020	1.16T
2019	701.59B
2018	535.81B
2017	464.63B
2016	294.62B

Net Income (KRW)

207940.KS Net Income (KRW) by year
Period	Net Income (KRW)
2025	1.78T
2024	1.08T
2023	857.69B
2022	798.06B
2021	393.59B
2020	240.97B
2019	202.9B
2018	227.88B
2017	-96.97B
2016	-176.82B

Operating Income (KRW)

207940.KS Operating Income (KRW) by year
Period	Operating Income (KRW)
2025	1.78T
2024	1.32T
2023	1.11T
2022	983.63B
2021	537.31B
2020	293.3B
2019	92.08B
2018	55.68B
2017	65.98B
2016	-30.42B

EBITDA (KRW)

207940.KS EBITDA (KRW) by year
Period	EBITDA (KRW)
2025	2.78T
2024	2.02T
2023	1.69T
2022	1.38T
2021	728.18B
2020	436.47B
2019	224.63B
2018	147.13B
2017	10.41B
2016	-122.99B

Cash Flows (KRW)

207940.KS Cash Flows (KRW) by year
Period	Cash Flows (KRW)
2025	809.95B
2024	299.28B
2023	560.9B
2022	-56.18B
2021	33.44B
2020	53.52B
2019	-171.04B
2018	-316.88B
2017	-354.99B
2016	-230.83B

EPS (KRW)

207940.KS EPS (KRW) by year
Period	EPS (KRW)
2025	38557.44
2024	23402.32
2023	18528.27
2022	17499.29
2021	9050.12
2020	5540.92
2019	4665.54
2018	5239.37
2017	-1531.84
2016	-4895.1

Expenses (KRW)

207940.KS Expenses (KRW) by year
Period	Expenses (KRW)
2025	2.21T
2024	2.27T
2023	1.92T
2022	1.52T
2021	669.43B
2020	324.66B
2019	314.78B
2018	357.76B
2017	560.13B
2016	195.07B

Cash & Debt (KRW)

207940.KS Cash & Debt (KRW) by year
Period	Cash & Debt (KRW)
2025	1.46T
2024	1.33T
2023	2.06T
2022	3.19T
2021	1.37T
2020	852.05B
2019	689.92B
2018	1.13T
2017	380.69B
2016	1.22T

Debt ratios

207940.KS Debt ratios by year
Period	Debt ratios
2025	-0.07
2024	0.03
2023	-0.03
2022	-0.25
2021	-0.05
2020	-0.08
2019	-0.14

Margins

207940.KS Margins by year
Period	Margins
2025	56.18%
2024	49.3%
2023	52.58%
2022	50.05%
2021	50.22%
2020	40.45%
2019	32.4%
2018	24.36%
2017	26.32%
2016	9.01%

Return on Capital

207940.KS Return on Capital by year
Period	Return on Capital
2025	23.95%
2024	9.93%
2023	8.72%
2022	8.88%
2021	7.89%
2020	5.24%
2019	4.66%
2018	5.48%
2017	-2.44%
2016	-4.33%

Shares Outstanding

207940.KS Shares Outstanding by year
Period	Shares Outstanding
2025	46.24M
2024	46.29M
2023	46.29M
2022	46.29M
2021	43.49M
2020	43.49M
2019	43.49M
2018	43.49M
2017	43.49M
2016	35.86M

Book Value Per Share (KRW)

207940.KS Book Value Per Share (KRW) by year
Period	Book Value Per Share (KRW)
2025	161139.94
2024	235567.95
2023	212367.25
2022	194086.85
2021	114764.36
2020	105743.46
2019	100125.4
2018	95549.98
2017	91433.68
2016	113851.29

Total Assets (KRW)

207940.KS Total Assets (KRW) by year
Period	Total Assets (KRW)
2025	11.06T
2024	17.34T
2023	16.05T
2022	16.58T
2021	7.97T
2020	6.42T
2019	5.91T
2018	5.98T
2017	7.18T
2016	7.53T

PE Ratio

207940.KS PE Ratio by year
Period	PE Ratio
Sep 26	34.84
Sep 26	35.63
Aug 26	36.59
Aug 26	38.19
Aug 26	38.11
Aug 26	38.31
Jul 26	36.56
Jul 26	37.38
Jul 26	34.37
Jul 26	34.35
Jul 26	34.99
Jun 26	34.8
Jun 26	35.61
Jun 26	33.56
Jun 26	34.72
May 26	35.32
May 26	36.67
May 26	36.77
May 26	38.15
Apr 26	38.09
Apr 26	39.6
Apr 26	41.49
Apr 26	40.71
Apr 26	40.27
Mar 26	46.58
Mar 26	46.44
Mar 26	46.18
Mar 26	47.69
Feb 26	51.57
Feb 26	50.35
Feb 26	49.6
Feb 26	48.38
Jan 26	50.62
Jan 26	52.27
Jan 26	56.48
Jan 26	54.47
Jan 26	48.82
Dec 25	60.91
Dec 25	62.39
Dec 25	60.91
Dec 25	59.07
Nov 25	57.85
Nov 25	67.58
Nov 25	67.58
Nov 25	67.58
Oct 25	67.58
Oct 25	65.2
Oct 25	61.83
Oct 25	56.12
Oct 25	55.85
Sep 25	55.63
Sep 25	56.96
Sep 25	57.74
Sep 25	57.29
Aug 25	55.68
Aug 25	57.29
Aug 25	57.46
Aug 25	56.85
Aug 25	57.52
Jul 25	59.3
Jul 25	58.46
Jul 25	58.8
Jul 25	57.74
Jun 25	65.44
Jun 25	66.75
Jun 25	66.95
Jun 25	66.95
May 25	67.8
May 25	66.75
May 25	65.83
May 25	68.33
May 25	71.28
Apr 25	68
Apr 25	68.92
Apr 25	68.66
Apr 25	70.23
Mar 25	70.94
Mar 25	74.05
Mar 25	71.07
Mar 25	74.39
Feb 25	75.47
Feb 25	78.24
Feb 25	79.8
Feb 25	78.44
Jan 25	73.1
Jan 25	73.51
Jan 25	68.64
Jan 25	67.62
Jan 25	63.57
Dec 24	64.64
Dec 24	64.99
Dec 24	68.24
Dec 24	66.58
Nov 24	67.48
Nov 24	64.64
Nov 24	64.85
Nov 24	69.49
Nov 24	69.07
Oct 24	73.43
Oct 24	73.36

Free Cash Flow Yield

207940.KS Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	2.23%
Sep 26	2.18%
Aug 26	2.12%
Aug 26	2.03%
Aug 26	2.04%
Aug 26	2.03%
Jul 26	2.12%
Jul 26	2.08%
Jul 26	2.26%
Jul 26	2.26%
Jul 26	2.22%
Jun 26	1.3%
Jun 26	1.27%
Jun 26	1.35%
Jun 26	1.31%
May 26	1.29%
May 26	1.24%
May 26	1.23%
May 26	1.19%
Apr 26	1.19%
Apr 26	1.15%
Apr 26	1.09%
Apr 26	1.11%
Apr 26	1.13%
Mar 26	1%
Mar 26	1%
Mar 26	1.01%
Mar 26	0.98%
Feb 26	0.9%
Feb 26	0.93%
Feb 26	0.94%
Feb 26	0.96%
Jan 26	0.92%
Jan 26	0.89%
Jan 26	0.83%
Jan 26	0.86%
Jan 26	0.96%
Dec 25	0.52%
Dec 25	0.51%
Dec 25	0.52%
Dec 25	0.54%
Nov 25	0.55%
Nov 25	0.47%
Nov 25	0.47%
Nov 25	0.47%
Oct 25	0.47%
Oct 25	0.49%
Oct 25	0.51%
Oct 25	0.57%
Oct 25	0.57%
Sep 25	0.22%
Sep 25	0.21%
Sep 25	0.21%
Sep 25	0.21%
Aug 25	0.22%
Aug 25	0.21%
Aug 25	0.21%
Aug 25	0.21%
Aug 25	0.21%
Jul 25	0.21%
Jul 25	0.21%
Jul 25	0.21%
Jul 25	0.21%
Jun 25	0.42%
Jun 25	0.41%
Jun 25	0.41%
Jun 25	0.41%
May 25	0.41%
May 25	0.41%
May 25	0.42%
May 25	0.4%
May 25	0.39%
Apr 25	0.41%
Apr 25	0.4%
Apr 25	0.4%
Apr 25	0.39%
Mar 25	1.36%
Mar 25	1.3%
Mar 25	1.36%
Mar 25	1.3%
Feb 25	1.28%
Feb 25	1.23%
Feb 25	1.21%
Feb 25	1.23%
Jan 25	1.32%
Jan 25	1.31%
Jan 25	1.41%
Jan 25	1.43%
Jan 25	1.52%
Dec 24	1.47%
Dec 24	1.46%
Dec 24	1.39%
Dec 24	1.43%
Nov 24	1.41%
Nov 24	1.47%
Nov 24	1.47%
Nov 24	1.37%
Nov 24	1.38%
Oct 24	1.3%
Oct 24	1.3%

Price to Sales

207940.KS Price to Sales by year
Period	Price to Sales
Sep 26	14.49
Sep 26	14.82
Aug 26	15.22
Aug 26	15.88
Aug 26	15.85
Aug 26	15.93
Jul 26	15.21
Jul 26	15.54
Jul 26	14.29
Jul 26	14.28
Jul 26	14.55
Jun 26	13.63
Jun 26	13.94
Jun 26	13.14
Jun 26	13.6
May 26	13.83
May 26	14.36
May 26	14.4
May 26	14.94
Apr 26	14.92
Apr 26	15.5
Apr 26	16.25
Apr 26	15.94
Apr 26	15.77
Mar 26	13.51
Mar 26	13.46
Mar 26	13.39
Mar 26	13.82
Feb 26	14.95
Feb 26	14.6
Feb 26	14.38
Feb 26	14.03
Jan 26	14.67
Jan 26	15.15
Jan 26	16.37
Jan 26	15.79
Jan 26	14.15
Dec 25	15.57
Dec 25	15.94
Dec 25	15.57
Dec 25	15.1
Nov 25	14.78
Nov 25	17.27
Nov 25	17.27
Nov 25	17.27
Oct 25	17.27
Oct 25	16.66
Oct 25	15.8
Oct 25	14.34
Oct 25	14.27
Sep 25	14.53
Sep 25	14.88
Sep 25	15.08
Sep 25	14.97
Aug 25	14.54
Aug 25	14.97
Aug 25	15.01
Aug 25	14.85
Aug 25	15.02
Jul 25	15.49
Jul 25	15.27
Jul 25	15.36
Jul 25	15.08
Jun 25	15.59
Jun 25	15.9
Jun 25	15.95
Jun 25	15.95
May 25	16.15
May 25	15.9
May 25	15.68
May 25	16.28
May 25	16.98
Apr 25	16.2
Apr 25	16.42
Apr 25	16.36
Apr 25	16.73
Mar 25	17.11
Mar 25	17.86
Mar 25	17.14
Mar 25	17.94
Feb 25	18.2
Feb 25	18.87
Feb 25	19.24
Feb 25	18.92
Jan 25	17.63
Jan 25	17.73
Jan 25	16.55
Jan 25	16.31
Jan 25	15.33
Dec 24	15.79
Dec 24	15.87
Dec 24	16.66
Dec 24	16.26
Nov 24	16.48
Nov 24	15.79
Nov 24	15.84
Nov 24	16.97
Nov 24	16.87
Oct 24	17.93
Oct 24	17.91

EV/EBITDA

207940.KS EV/EBITDA by year
Period	EV/EBITDA
Sep 26	22.8
Sep 26	23.32
Aug 26	23.95
Aug 26	25.01
Aug 26	24.96
Aug 26	25.09
Jul 26	23.94
Jul 26	24.47
Jul 26	22.49
Jul 26	22.48
Jul 26	22.9
Jun 26	22.14
Jun 26	22.65
Jun 26	21.34
Jun 26	22.09
May 26	22.47
May 26	23.33
May 26	23.4
May 26	24.28
Apr 26	24.25
Apr 26	25.21
Apr 26	26.43
Apr 26	25.93
Apr 26	25.64
Mar 26	26.55
Mar 26	26.47
Mar 26	26.32
Mar 26	27.18
Feb 26	29.42
Feb 26	28.72
Feb 26	28.28
Feb 26	27.58
Jan 26	28.87
Jan 26	29.82
Jan 26	32.24
Jan 26	31.09
Jan 26	27.83
Dec 25	34.46
Dec 25	35.29
Dec 25	34.46
Dec 25	33.42
Nov 25	32.72
Nov 25	38.24
Nov 25	38.24
Nov 25	38.24
Oct 25	38.24
Oct 25	36.89
Oct 25	34.98
Oct 25	31.74
Oct 25	31.58
Sep 25	31.11
Sep 25	31.85
Sep 25	32.29
Sep 25	32.04
Aug 25	31.14
Aug 25	32.04
Aug 25	32.13
Aug 25	31.79
Aug 25	32.16
Jul 25	33.16
Jul 25	32.69
Jul 25	32.88
Jul 25	32.29
Jun 25	35.18
Jun 25	35.89
Jun 25	35.99
Jun 25	35.99
May 25	36.45
May 25	35.89
May 25	35.4
May 25	36.74
May 25	38.32
Apr 25	36.56
Apr 25	37.05
Apr 25	36.91
Apr 25	37.76
Mar 25	37.56
Mar 25	39.2
Mar 25	37.63
Mar 25	39.38
Feb 25	39.96
Feb 25	41.43
Feb 25	42.25
Feb 25	41.53
Jan 25	38.7
Jan 25	38.92
Jan 25	36.34
Jan 25	35.8
Jan 25	33.65
Dec 24	33.06
Dec 24	33.23
Dec 24	34.89
Dec 24	34.05
Nov 24	34.51
Nov 24	33.06
Nov 24	33.16
Nov 24	35.53
Nov 24	35.32
Oct 24	37.54
Oct 24	37.51

Price/Operating Cashflow

207940.KS Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Sep 26	28.05
Sep 26	28.69
Aug 26	29.46
Aug 26	30.75
Aug 26	30.69
Aug 26	30.85
Jul 26	29.44
Jul 26	30.09
Jul 26	27.67
Jul 26	27.65
Jul 26	28.17
Jun 26	27.63
Jun 26	28.26
Jun 26	26.64
Jun 26	27.57
May 26	28.04
May 26	29.11
May 26	29.19
May 26	30.28
Apr 26	30.24
Apr 26	31.43
Apr 26	32.93
Apr 26	32.32
Apr 26	31.97
Mar 26	33.56
Mar 26	33.46
Mar 26	33.27
Mar 26	34.35
Feb 26	37.15
Feb 26	36.28
Feb 26	35.73
Feb 26	34.86
Jan 26	36.46
Jan 26	37.66
Jan 26	40.69
Jan 26	39.24
Jan 26	35.17
Dec 25	33.52
Dec 25	34.34
Dec 25	33.52
Dec 25	32.51
Nov 25	31.84
Nov 25	37.2
Nov 25	37.2
Nov 25	37.2
Oct 25	37.2
Oct 25	35.89
Oct 25	34.03
Oct 25	30.89
Oct 25	30.74
Sep 25	34.68
Sep 25	35.51
Sep 25	36
Sep 25	35.72
Aug 25	34.71
Aug 25	35.72
Aug 25	35.82
Aug 25	35.44
Aug 25	35.86
Jul 25	36.97
Jul 25	36.45
Jul 25	36.66
Jul 25	36
Jun 25	42.72
Jun 25	43.58
Jun 25	43.71
Jun 25	43.71
May 25	44.27
May 25	43.58
May 25	42.98
May 25	44.61
May 25	46.54
Apr 25	44.4
Apr 25	45
Apr 25	44.83
Apr 25	45.85
Mar 25	35.51
Mar 25	37.07
Mar 25	35.58
Mar 25	37.24
Feb 25	37.78
Feb 25	39.17
Feb 25	39.94
Feb 25	39.27
Jan 25	36.59
Jan 25	36.8
Jan 25	34.36
Jan 25	33.85
Jan 25	31.82
Dec 24	40.2
Dec 24	40.42
Dec 24	42.44
Dec 24	41.41
Nov 24	41.97
Nov 24	40.2
Nov 24	40.33
Nov 24	43.21
Nov 24	42.96
Oct 24	45.67
Oct 24	45.63

Price to Book

207940.KS Price to Book by year
Period	Price to Book
Sep 26	8.26
Sep 26	8.45
Aug 26	8.67
Aug 26	9.05
Aug 26	9.03
Aug 26	9.08
Jul 26	8.67
Jul 26	8.86
Jul 26	8.15
Jul 26	8.14
Jul 26	8.29
Jun 26	8.33
Jun 26	8.53
Jun 26	8.04
Jun 26	8.32
May 26	8.46
May 26	8.78
May 26	8.81
May 26	9.13
Apr 26	9.12
Apr 26	9.48
Apr 26	9.94
Apr 26	9.75
Apr 26	9.64
Mar 26	6.1
Mar 26	6.09
Mar 26	6.05
Mar 26	6.25
Feb 26	6.76
Feb 26	6.6
Feb 26	6.5
Feb 26	6.34
Jan 26	6.63
Jan 26	6.85
Jan 26	7.4
Jan 26	7.14
Jan 26	6.4
Dec 25	6.75
Dec 25	6.91
Dec 25	6.75
Dec 25	6.55
Nov 25	6.41
Nov 25	7.49
Nov 25	7.49
Nov 25	7.49
Oct 25	7.49
Oct 25	7.23
Oct 25	6.85
Oct 25	6.22
Oct 25	6.19
Sep 25	6.31
Sep 25	6.46
Sep 25	6.55
Sep 25	6.5
Aug 25	6.32
Aug 25	6.5
Aug 25	6.52
Aug 25	6.45
Aug 25	6.52
Jul 25	6.73
Jul 25	6.63
Jul 25	6.67
Jul 25	6.55
Jun 25	6.5
Jun 25	6.63
Jun 25	6.65
Jun 25	6.65
May 25	6.74
May 25	6.63
May 25	6.54
May 25	6.79
May 25	7.08
Apr 25	6.76
Apr 25	6.85
Apr 25	6.82
Apr 25	6.98
Mar 25	7.05
Mar 25	7.36
Mar 25	7.06
Mar 25	7.39
Feb 25	7.5
Feb 25	7.77
Feb 25	7.93
Feb 25	7.8
Jan 25	7.26
Jan 25	7.3
Jan 25	6.82
Jan 25	6.72
Jan 25	6.32
Dec 24	6.44
Dec 24	6.47
Dec 24	6.79
Dec 24	6.63
Nov 24	6.72
Nov 24	6.44
Nov 24	6.46
Nov 24	6.92
Nov 24	6.88
Oct 24	7.31
Oct 24	7.3

No video analysis for this stock yet. Request one from our team.

News: 207940.KS

prnewswire.com · 22 Jul 2026

Samsung Biologics Reports Second Quarter 2026 Financial Results

/PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), reported financial results for the

prnewswire.com · 19 Jul 2026

Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India

Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding therefrom any treasury shares) at

prnewswire.com · 30 Jun 2026

Samsung Biologics Releases 2026 ESG Report, Highlighting Progress in Sustainable Operations and Responsible Growth

/PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), published its annual environmental,